Home › Funds › Harvard Management Company › PLRX
Harvard Management Company position in PLRX
PLIANT THERAPEUTICS INC · Health Care
Latest position (Q1 2023)281.19K sh
Reported value held$7.48M
Portfolio Weight0.80%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 562.38K | $9.49M | New |
| Q4 2021 | 562.38K | $7.59M | Hold |
| Q1 2022 | 562.38K | $3.94M | Hold |
| Q2 2022 | 562.38K | $4.50M | Hold |
| Q3 2022 | 562.38K | $11.75M | Hold |
| Q4 2022 | 562.38K | $10.87M | Hold |
| Q1 2023 | 281.19K | $7.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLRX
- Vanguard Group 2.82M sh · $3.44M · Q4 2025
- Two Sigma Investments 2.26M sh · $2.58M · Q2 2026
- Citadel Advisors 2.14M sh · $2.44M · Q2 2026
- Renaissance Technologies 2.05M sh · $2.34M · Q2 2026
- BlackRock Inc 1.15M sh · $1.31M · Q2 2026
- Marshall Wace 835.12K sh · $952.04K · Q2 2026
- JPMorgan Chase & Co 681.65K sh · $783.89K · Q2 2026
- Geode Capital Management 578.58K sh · $659.95K · Q2 2026
- UBS Group AG 571.76K sh · $651.81K · Q2 2026
- Millennium Management 559.45K sh · $637.77K · Q2 2026
- Morgan Stanley 298.98K sh · $340.83K · Q2 2026
- Goldman Sachs Group 208.59K sh · $237.79K · Q2 2026